Shanghai MicroPort Medical (Group) Co., Ltd. Won A Patent Right Lawsuit Against NewMed Medical Co., Ltd.


Shanghai, China – On June 13, The Shanghai Intellectual Property Court delivered the first-instance judgment for the case of Shanghai MicroPort Medical (Group) Co., Ltd vs NewMed Medical Co., Ltd. and Yu Qifeng, Wang Haishan, Qin Tao, Liang Yuchen and Chen Jing over ownership of patent application and patent right disputes. The court ruled that the patent right for the utility model named Electropolishing Devices of the application number 201620366783.X and the patent application right for the invention named Electropolishing Devices of the application number 201610269615.3 should fall under the ownership of Shanghai MicroPort Medical (Group) Co., Ltd.
The plaintiff, namely Shanghai MicroPort Medical (Group) Co., Ltd ("The Group") has been engaged in the R&D, manufacturing and sales of high-end medical devices since 1998, and has been dedicated to technological innovation and breakthroughs. The Group has built up the ownership of over 3,100 patents or patent applications and created nearly 100 know-hows that are unique and never open to the public. The defendant of NewMed Medical Co., Ltd. ("NewMed Medical") was founded in March 2015, with the other defendants, namely Yu Qifeng, Qin Tao, Wang Haishan and Liang Yuchen, being former employees of The Group. Qin Tao, Wang Haishan and Liang Yuchen, who left The Group after February 2015, had owned the authority and opportunity to be in contact with the electropolishing technology and related devices. After leaving the Group, the three former employees filed patent applications about the technology, which is exclusively owned by The Group, in the name of NewMed Medical without the authorization of The Group, which seriously infringed on the legal rights of The Group. After learning the event, The Group filed a lawsuit at the Shanghai Intellectual Property Court to firmly defend its legal rights by judicial means. The Shanghai Intellectual Property Court has ascertained and established the facts that the technology had essentially existed at The Group before the departures of Qin Tao and Wang Haishan, while NewMed Medical failed to submit any evidence to support its argument that Yu Qifeng, the inventor, actually completed the invention of the technology at issue. Therefore, the rights basis of NewMed Medical for the patent and pending patent in disputes does not exist. The Shanghai Intellectual Property Court decided that the right of the patent and pending patent in disputes should be both owned by The Group.
During the past 20 years since its establishment, The Group has been focused on independent innovation. The Group not only values R&D and accumulation of technologies on its own, but also owns the capability and resolve to defend its own rights by judicial means. Previously, The Group had by judicial means won back joint ownerships of six patents or patent applications, which had been in rights disputes involving NewMed Medical.

About MicroPort®

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 8 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Cardiac Rhythm Management, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to bringing about a people-centric SuperCluster of emerging medical technologies to provide the best yet accessible ways & means to prolong and reshape lives.

For more information, please refer to:

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2019 MicroPort Scientific Corporation

Leanne Li
Board Secretary and Vice President of Corporate General Affairs MicroPort Scientific Corporation
Shanghai MicroPort Medical (Group) Co., Ltd. (HQ)
Tel: (86)(21) 38954600-6957